AFP and neoplasm: In LDR patients, patients given S-TACE therapy had better OS than those given TACE monotherapy in patients with AFP≥400 ng/ml, AFP<400 ng/ml, TB<28 g/L, TB>28 g/L, and maximum diameter of tumor < 5 cm group (p<0.001,<0.001, <0.001, <0.001, and <0.001, respectively).